- Home
- ARQT vs BHF Comparison
ARQT vs BHF Comparison
Compare ARQT & BHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- BHF
- Stock Information
- Founded
- ARQT 2016
- BHF 2016
- Country
- ARQT United States
- BHF United States
- Employees
- ARQT N/A
- BHF N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- BHF Life Insurance
- Sector
- ARQT Health Care
- BHF Finance
- Exchange
- ARQT Nasdaq
- BHF Nasdaq
- Market Cap
- ARQT 3.3B
- BHF 3.8B
- IPO Year
- ARQT 2020
- BHF N/A
- Fundamental
- Price
- ARQT $28.01
- BHF $65.75
- Analyst Decision
- ARQT Strong Buy
- BHF Hold
- Analyst Count
- ARQT 7
- BHF 9
- Target Price
- ARQT $22.17
- BHF $58.88
- AVG Volume (30 Days)
- ARQT 3.1M
- BHF 2.2M
- Earning Date
- ARQT 10-28-2025
- BHF 11-06-2025
- Dividend Yield
- ARQT N/A
- BHF N/A
- EPS Growth
- ARQT N/A
- BHF N/A
- EPS
- ARQT N/A
- BHF 14.74
- Revenue
- ARQT $317,929,000.00
- BHF $7,830,000,000.00
- Revenue This Year
- ARQT $85.27
- BHF $42.07
- Revenue Next Year
- ARQT $30.70
- BHF $3.92
- P/E Ratio
- ARQT N/A
- BHF $4.45
- Revenue Growth
- ARQT 129.21
- BHF 48.75
- 52 Week Low
- ARQT $9.19
- BHF $42.07
- 52 Week High
- ARQT $28.96
- BHF $66.33
- Technical
- Relative Strength Index (RSI)
- ARQT 71.06
- BHF 71.07
- Support Level
- ARQT $22.26
- BHF $65.51
- Resistance Level
- ARQT $24.39
- BHF $65.92
- Average True Range (ATR)
- ARQT 1.46
- BHF 1.26
- MACD
- ARQT 0.21
- BHF 0.69
- Stochastic Oscillator
- ARQT 85.67
- BHF 95.77
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.